Medical Technology - Worldwide
Worldwide- Revenue in the Medical Technology market is projected to reach US$670.70bn in 2026.
- The market's largest market is Medical Devices with a projected market volume of US$576.85bn in 2026.
- Revenue is expected to show an annual growth rate (CAGR 2026-2031) of 5.18%, resulting in a market volume of US$863.32bn by 2031.
- In global comparison, most revenue will be generated United States (US$246.42bn in 2026).
- Key regions:
- United States,
- Germany,
- China,
- Japan,
- France
Definition:
The Medical Technology market covers devices and products used for prevention, diagnosis, and treatment of diseases. Next to pharmaceuticals, they form the most important category of medical products. The most well known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants.
Structure:
The Medical Technology market consists of two markets, In Vitro Diagnostics (IVD) and Medical Devices. The IVD market covers products used for medical laboratory testing of specimens derived from the human body. The Medical Devices market covers a broad range of products which are further marketed into medical specialties or types of application: Cardiology Devices, Diagnostic Imaging Devices, Orthopedic Devices, Ophthalmic Devices, and General & Plastic Surgery Devices. The Other Medical Devices market provides information on additional areas that are not covered by the main markets.
Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.
Company examples: Medtronic, Johnson & Johnson, Abbott Laboratories, Siemens Healthineers.
Further information on the key players can be found in the Market Shares boxes.
- Implants and prostheses
- Assistive technology products (e.g., hearing aids, wheelchairs)
- Clinical engineering products
- Imaging devices
- Products for laboratoy testing (IVD)
- Active medical devices (i.e., operating with electrical energy)
- Pharmaceuticals
- Services (i.e., treatment expenses)
- Consumer technologies, e.g., fitness trackers
- Blood and transplants derived from the human body
Revenue
Key Players
Research & development
Analyst Opinion
The Medical Technology market is experiencing significant growth and development worldwide.
Customer preferences: Customers in the Medical Technology market worldwide are increasingly seeking innovative and advanced medical devices and technologies. They are looking for products that offer improved accuracy, efficiency, and patient comfort. Additionally, there is a growing demand for wearable medical devices that can monitor health conditions in real-time and provide personalized data to users. Customers also prioritize products that are cost-effective and provide value for money.
Trends in the market: One of the key trends in the Medical Technology market worldwide is the increasing adoption of telemedicine and remote patient monitoring technologies. This trend has been accelerated by the COVID-19 pandemic, as healthcare providers and patients seek alternative ways to deliver and receive care. Telemedicine allows for virtual consultations, remote diagnosis, and monitoring of patients, reducing the need for in-person visits and improving access to healthcare services, especially in rural and underserved areas. Another trend in the market is the rise of artificial intelligence (AI) and machine learning (ML) in medical technology. AI and ML algorithms are being used to analyze large amounts of medical data, improve diagnostic accuracy, and develop personalized treatment plans. These technologies have the potential to revolutionize healthcare by enabling early detection of diseases, predicting patient outcomes, and optimizing treatment strategies. The increasing focus on patient-centric care is also driving the adoption of medical technology worldwide. Healthcare providers are prioritizing patient satisfaction and outcomes, leading to the development of technologies that enhance patient experience and engagement. This includes the use of mobile apps for appointment scheduling, medication reminders, and health monitoring, as well as the integration of electronic health records (EHRs) to improve the coordination and continuity of care.
Local special circumstances: In different countries and regions, there are unique factors influencing the development of the Medical Technology market. For example, in developed countries with aging populations, there is a higher demand for medical devices and technologies that cater to the needs of elderly patients. In emerging economies, there is a growing middle class with increasing disposable income, driving the demand for affordable and accessible healthcare solutions. Regulatory frameworks and reimbursement policies also play a significant role in shaping the Medical Technology market. Countries with favorable regulations and reimbursement systems for medical devices and technologies tend to attract more investment and innovation in the sector. On the other hand, stringent regulations and reimbursement limitations can hinder market growth and adoption of new technologies.
Underlying macroeconomic factors: The growth of the Medical Technology market worldwide is also influenced by macroeconomic factors such as GDP growth, healthcare expenditure, and government initiatives. Countries with robust economies and higher healthcare spending tend to have a more developed and advanced Medical Technology market. Government initiatives to promote digital healthcare, improve healthcare infrastructure, and enhance healthcare access also contribute to market growth. In conclusion, the Medical Technology market is experiencing significant growth and development worldwide. Customer preferences for innovative and advanced medical devices, the adoption of telemedicine and AI, and the focus on patient-centric care are driving market trends. Local special circumstances and underlying macroeconomic factors further shape the market dynamics in different countries and regions.
Global Comparison
Methodology
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.Modeling approach / Market size:
Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.Explore more high-quality data on related topic
Medical technology industry - statistics & facts
Medical technology is a large and still expanding market. Global medtech market revenue is modeled at about 635 billion U.S. dollars in 2025, with steady growth projected through 2031. The United States holds nearly 48 percent of the global device market, compared with about 26 percent for Europe. This split reflects the depth of high-income healthcare spending in these two regions. It suggests that global demand is closely tied to reimbursement and procurement conditions in just two markets. The Asian-Pacific market is led by China, followed by Japan and South Korea, yet the region starts from a much smaller base. This indicates that any geographic rebalancing is likely to be gradual, with the two established regions continuing to set the pace.
Scale concentrates around established leaders
Within this market, medical devices dominate, and individual categories are shaped by a few large players. In the global diagnostic imaging market, General Electric holds about 30 percent of share and Siemens Healthineers some 29 percent, so two companies together control close to three-fifths of the segment. Medtronic, the largest company by revenue, generates its biggest segment in cardiovascular care. This points to a different pattern: depth in one core specialty rather than a head-to-head duopoly. Both are supported by substantial reinvestment, as U.S. and European companies are spending over 35 billion U.S. dollars annually on R&D. Spending at this scale is a high hurdle for newcomers and helps explain why a few companies hold large shares. It also increases reliance on a small group of incumbents for innovation, which raises the industry's sensitivity to company-specific setbacks.
AI raises the technical and regulatory bar
Innovation is increasingly software-driven. FDA approvals of AI/ML-enabled medtech products rose from just 6 in 2015 to a preliminary figure of roughly 335 in 2025, and GE HealthCare and Siemens Healthineers lead cumulative AI/ML approvals. These are the same two companies that dominate diagnostic imaging, which indicates that AI is currently reinforcing, rather than disrupting, incumbent positions. A growing volume of AI-enabled products also expands the regulatory workload attached to each innovation. For smaller digital players in the EU this is already visible: about 40 percent of EU digital health companies cite the MDR and IVDR among their greatest compliance challenges. This points to a structure in which regulatory capacity becomes a competitive factor in its own right, one that may favor organizations able to spread compliance costs across large portfolios.
Strategic outlook
The sector's next phase will likely depend less on demand than on the conditions under which scale is converted into growth. U.S. trade policy remains unsettled: after a Supreme Court ruling curtailed one tariff authority in early 2026, replacement measures followed and a sector-specific investigation remains open. With the U.S. making up nearly half of the global device market, such shifts reach beyond its borders, and because device prices are embedded in procedure reimbursement, costs cannot easily be passed on. In Europe, the AI Act amendment in force keeps medical devices within its high-risk scope, with obligations for AI-enabled devices deferred to 2028. Dual compliance is likely to persist, burdening smaller players while favoring organizations that can spread regulatory effort across large portfolios.
AI is becoming part of the incumbents' core offering, not a threat to it: the leading imaging companies hold the largest portfolios of authorized AI devices, among more than 1,600 in the U.S. Reimbursable AI products generate revenue, and as payment models shift from fee-for-service toward outcome- and value-based structures, demonstrated clinical and economic benefit decides which AI products scale. Authorizations remain concentrated in radiology, so it is less clear how quickly the pattern will extend to other specialties; that, together with regulation and payment conditions, will shape whether today's concentration deepens or loosens.
Get in touch with us for additional information
Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.